Equities

Protect Pharmaceutical Corporation Inc

PRTT:PKC

Protect Pharmaceutical Corporation Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)1.00
  • Today's Change0.00 / 0.00%
  • Shares traded13.00k
  • 1 Year change+53.85%
  • Beta3.5193
Data delayed at least 15 minutes, as of Nov 06 2024 15:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Protect Pharmaceutical Corporation, Inc. is engaged in providing services in the field of international road, seaway, airline freight as well as intermodal transportation freight. The Company combines all transportation servicing needs. The Company’s subsidiary is Antarax Capital Danismanlik Limited.

  • Revenue in USD (TTM)0.00
  • Net income in USD-15.04k
  • Incorporated2020
  • Employees3.00
  • Location
    Protect Pharmaceutical Corporation Inc12465 South Fort Street, Suite 240DRAPER 84020United StatesUSA
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PRTT:PKC since
announced
Transaction
value
Bosfor ExportDeal completed24 Nov 202324 Nov 2023Deal completed5.26%1.90m
Data delayed at least 15 minutes, as of Nov 06 2024 15:42 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PS International Group Ltd0.00-1.12m18.17m----0.4656-----0.3106-0.31060.001.610.00-------9.85---14.11--------------0.1654-------224.63------
Jayud Global Logistics Ltd84.31m-9.40m28.95m175.00------0.3434-0.4433-0.44333.99-0.23985.56--11.12481,766.00-68.10---405.47---3.00---12.25-----24.7436.94---23.64---1,966.34------
Janel Corp171.35m565.00k36.18m316.0068.421.8811.150.21120.44580.4458141.0816.221.6523.825.43542,250.000.84470.61012.281.7432.9224.850.5130.32810.57891.280.6387---41.1622.52114.03-16.3532.25--
Air T Inc281.81m-6.62m42.12m624.00--10.22--0.1495-2.35-2.35100.581.491.553.6810.28451,623.40-2.55-1.13-3.80-1.7420.2521.20-1.64-0.8430.91590.39150.9027--15.985.8944.54---44.52--
United Express Inc240.73k-2.48m43.18m1.00--3.42434.04179.36-0.1074-0.10740.01120.43010.0351-------36.15-36.21-39.28-39.4575.2611.60-1,030.68-87.59----0.00---18.7921.76-34,698.88------
Protect Pharmaceutical Corporation Inc0.00-15.04k57.45m3.00---------0.0135-0.01350.00-0.13640.00-------149.88-22,566.05---------------0.0495---------193.96------
Freightos Ltd21.38m-20.41m70.07m350.00--1.09--3.28-0.426-0.4260.44581.330.2384--9.4761,080.00-22.75---27.32--61.27---95.45------0.0148--6.27---165.06------
SHENGFENG DEVELOPMENT Ltd446.28m8.89m106.83m1.34k12.090.95136.690.23940.10710.10715.371.361.81--4.88332,797.203.59--6.99--10.04--1.98----7.690.321--9.13--32.19------
Quhuo Ltd - ADR504.74m-5.57m130.06m490.00--0.2261--0.2577-5.53-5.53731.946.413.47--7.651,030,076.00-3.37-4.57-6.19-9.193.475.87-0.9709-1.36---13.900.1886---3.0920.22125.39---2.02--
Armlogi Holding Corp-100.00bn-100.00bn241.89m200.00--6.16----------0.9425----------------------------0.0082--23.65---46.55------
Data as of Nov 06 2024. Currency figures normalised to Protect Pharmaceutical Corporation Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.